Biotech stocks, which have beaten down over the past couple years, seem to make a selective comeback. Over the past few weeks, I've had a few biotech stocks pop 15-25% in one day. In absolute terms, the gains are small, since many have low single digit prices.
Over the years, I have dollar cost averaged down on several positions. As the biotech resurgence is taking place, I will use the opportunity to sell the lower priced shares at a profit, while holding the high cost shares for longer term gains.
That way I will reduce my cost basis for positions I keep, mitigating the downside pain if the biotechs should fall again.
For more on Strategies and Plans, check back Mondays for a new segment.
This is not financial advice. Please consult a professional advisor.
Copyright © 2017 Achievement Catalyst, LLC
No comments:
Post a Comment
Comment guidelines: My Wealth Builder will publish comments that are about the topic and do not contain inappropriate language. My Wealth Builder reserves the right to edit or delete comments for any reason which includes those that have advertising (either for a product, website, or blog), contain inappropriate language or are not about the topic.